Adrenaline action in normal and insulin-resistant Zucker rat skeletal muscles : Effect on insulin-stimulated glucose uptake and glycogen breakdown by Alhaj, Nader Ibrahim Mahmoud
1 
 
Adrenaline action in normal and insulin-
resistant Zucker rat skeletal muscles  
Effect on insulin-stimulated glucose uptake and glycogen breakdown 
Nader I. M. Alhaj 
 
 
 
 
 
Master thesis in pharmacology for the degree Master of 
Pharmacy 
Department of Pharmaceutical Biosciences, 
School of Pharmacy, Faculty of Mathematics and Natural 
Sciences 
University of Oslo 
Autumn 2010 
 
                                     
2 
 
Adrenaline action in normal and insulin-
resistant skeletal muscles in Zucker rats 
Effect on insulin-stimulated glucose uptake and glycogen breakdown 
Nader I. M. Alhaj 
 
 
This thesis was conducted between August.2009 and September 2010 at the National Institute of 
Occupational Health (STAMI) and the Norwegian School of Sport Sciences 
 
 
                                                               
 
 
Master thesis in pharmacology for the degree Master of 
Pharmacy 
Department of Pharmaceutical Biosciences, 
School of Pharmacy, Faculty of Mathematics and Natural 
Sciences 
University of Oslo 
Advisors 
Professor Jørgen Jensen 
Professor Arild C Rustan 
 
3 
 
Preface 
 
My best thanks and regards to my external advisor who helped me through this job, followed me step 
by step, learned me exactly how to WORK SMARTER NOT HARDER, my special thanks and appreciations 
to Jørgen Jensen. 
 Too much thanks to my internal advisor Arild Rustan.  
My thanks to: 
 Eva Skovlund, Dr. Bassam Banat, Dr. Ahmed Batran and Dr. Shaher Shalfawi for their help in 
statistics. 
 Ada Ingvaldsen, Astrid Bolling and Jorid Thrane Stuenæs for their help in the practical work and 
procedures. 
 My friends and colleagues in the school of pharmacy and in Apotek1 St. Hanshaugen. 
 My cousin, BESc. Ismael for his technical support. 
A warm gratitude and thanks to my family members for their support and positive directions. 
My great love to my wife and son, I thank them for being the best family and friends for me during my 
work in this project. 
 
At the end, I dedicate this simple and modest job to every Palestinian student who can’t reach his or her 
school because of the occupation, I hope they can get their schools and graduate at the scheduled time, 
and hope all Palestinian children can go to school in peace and without occupational borders. 
 
My best wishes and regards. 
 
Nader Alhaj 
11.09.2010  
 
 
 
 
4 
 
Table of contents 
 
Abbreviations…………………………………………………………………………………………………………………………………5 
Abstract………………………………………………………………………………………………………………………………………….6 
1 Background……………………………………………………………………………………………………………….7 
 
1.1 Diabetes……………………………………………………………………………………………………………………..7 
1.2 Animal model (Zucker rat)…………………………………………………………………………………………..9 
1.3 Carbohydrates…………………………………………………………………………………………………………….10 
1.4 Glycogen………………………………………………………………………………………………………………………10 
1.5 Synthesis of glycogen…………………………………………………………………………………………………..11 
1.6 Regulation of glycogen synthesis………………………………………………………………………………….12 
1.7 Glycogenlysis (Adrenaline effect in skeletal muscles)…………………………………………………...15 
1.8 Insulin and Adrenaline effects in relation to glucose kinetics…………………………..……………16 
1.9 β-adrenergic signaling and insulin resistance in skeletal muscles…..………………………………18 
1.10 β-adrenergic signaling (the role of receptor content and exercise)……..……………………18 
 
2 Aims………………………………………………………………………………………………………….……………………. 20 
 
3 Materials and methods……………………………………………………..……………………………………..21 
3.1 Rats and muscles………………………………………………………………………………………………………….21 
3.2  Glucose uptake and glycogen content………………………………………………………………………….25 
3.3 Liver glycogen……………………………………………………………………………………………………………….26 
3.4 Statistics……………………………………………………………………………………………………………………….26 
 
4 Results……………………………………………………………………………………………………………………………27 
4.1 Glucose uptake and glycogen content……………………………………………………………………………27 
4.2 Liver glycogen and muscle weight……….. ……………………………………………………………………….34 
   
5 Discussion………………………………………………………………………………………………………………….……35 
5 
 
 
6 Conclusion………………………………………………………..…………………………………………………………..41 
 
 
7 References…………………………………………………………………………………………………………………..42   
8 Appendices...................................................................................................................... 47 
 
 
Abbreviations 
ANOVA                   Analysis Of Variance 
ADP                         Adenosine diphosphate 
ATP                          Adenosine triphosphate 
cAMP                      Cyclic adenosine monophosphate 
CVA                         cerebrovascular accident  
dw                           Dry weight (freeze-dried) 
EDL                          Extensor Digitorium Longus 
GS                            Glycogen synthase 
PI3-Kinase             Phosphatidylinositol 3-kinase 
PKA                        cAMP dependent protein kinase 
PKB                     Protein kinase B (AKT) 
rEDL                       red Extensor Digitorium Longus 
wEDL                     white Extensor Digitorium Longus 
BW                        Body weight 
 
6 
 
Abstract 
 
Carbohydrates are the major source of energy for most humans and account for about 60% of the 
energy consumed. In the human body carbohydrates are stored as glycogen in the liver and in the 
skeletal muscles. Regulation of glycogen synthesis is of great importance in the process of blood 
glucose homeostasis as glucose is stored as glycogen. Insulin and adrenaline are the most important 
hormones which regulate glycogen breakdown and glucose uptake. Adrenaline normally contrasts 
the effect of insulin in metabolic regulation. Insulin stimulates glucose uptake and synthesis of 
glycogen and lipids leading to energy accumulation whereas adrenaline decreases insulin-stimulated 
glucose uptake, increases energy expenditure and stimulates breakdown of glycogen and lipids. 
The aim of this study was to investigate the effect of adrenaline on insulin-stimulated glucose 
uptake and glycogen breakdown in soleus and EDL muscles from lean and insulin resistant obese 
Zucker rat. 
Experiments were done in vitro, as muscles were surgically removed from rats and incubated with 
insulin, adrenaline or insulin and adrenaline together. Other muscles were stimulated electrically. 
Glucose uptake was calculated from the intracellular accumulation of ³H-deoxy-D-glucose during 
incubation while glycogen content was measured through hydrolyzing of glycogen with 
amyloglucosidase. The formed glucose measured indirectly by measuring the amount of hexokinase 
and glucose-6-phosphate dehydrogenase fluorometrically. 
In this study my results showed that adrenaline decreased insulin-stimulated glucose uptake in 
soleus and EDL muscles from lean and obese Zucker rats. Adrenaline was without effect on basal 
glucose uptake in soleus muscles from lean and obese Zucker rats. We found also that, glycogen 
content was higher in soleus muscles from obese Zucker rats than in soleus muscles from lean 
littermates in control rested state and after exposure to adrenaline. Adrenaline stimulated glycogen 
breakdown in insulin resistant EDL muscles but not in normal muscles.  
In conclusion, adrenaline decreased insulin-stimulated glucose uptake in both normal and insulin 
resistant muscles. Furthermore adrenaline stimulated glycogen breakdown in EDL but not soleus 
muscles from obese Zucker rats. This suggests that β-adrenergic signaling is not impaired in insulin 
resistant muscles. 
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1. Background 
 
1.1 Diabetes 
Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin (type I), or 
when the body cannot effectively respond to insulin (Type II). In a generation, diabetes has had a six-fold 
increase. In 1985 there were an estimated 30 million people with diabetes. Today diabetes affects more 
than 230 million people, almost 6% of the world's adult population (WHO, World diabetes foundation). 
The most important type is type II as it accounts for 90% of diabetes cases in the world. Type II diabetes 
can really managed or even prevented by a healthy diet and regular exercise.  
The human body has the ability to manage the blood glucose level within 4-8 mmol/l despite food 
intake. The first step in the metabolism of glucose in muscles is the stimulation of cells by insulin. Insulin 
stimulates muscle cells to take up glucose and to store it as glycogen. This storage is crucial to maintain 
blood glucose within narrow limits despite continuous utilization of glucose and supply of carbohydrates 
in larger meals. Despite that carbohydrates are essential, the body contains limited amount of it. The 
total human body content of carbohydrates is nearly 500 g distributed as (4 g blood glucose, 80 g liver 
glycogen and 400 g muscle glycogen). Skeletal muscles managing about 80%of the insulin-stimulated 
glucose uptake in the human body (DeFronzo et al., 1981). And 70-90% of the glucose in the human 
body converts to glycogen in the skeletal muscles (Shulman et al., 1990).  
One of the major causes of the type II diabetes is the defect or decrease in the insulin sensitivity in the 
cell. The major part of the body, which is of special importance in the study of the insulin sensitivity is 
skeletal muscle as some studies have reported that the chronic insulin resistance is in large part due to 
the skeletal muscle insulin resistance (Ivy et al., 1986).  
Insulin resistance is generally defined as a decreased ability of insulin to stimulate usage and storage of 
glucose, precedes the development of diabetes and is detectable prior to the development of 
hyperglycaemia. This reduction in insulin ability to exert its action stimulates insulin production by 
pancreas, which results in hyperinsulinemia which is the most important symptom of insulin resistance.  
Insulin resistance results in decrease of glucose uptake into the muscle cells leading to increase glucose 
level in the blood. There are clear interactions between adrenergic and insulinergic systems that affect 
the net result of glucose uptake. Adrenaline stimulates glycogenolysis in skeletal muscles and 
accumulates glucose 6-phosphate, which inhibits hexokinase and phosphorylation of glucose and limit 
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glucose uptake process. As well, previous studies have reported that adrenaline decreases insulin-
stimulated glucose transport but only when insulin is within a low to moderate physiological range. This 
supports the fact that adrenaline inhibits glucose uptake in skeletal muscles but not in the absence of 
insulin, which may indicate a different effect of adrenaline in normal skeletal muscles and insulin-
resistant skeletal muscles on glucose uptake.  
Adrenaline could inhibit the effect of insulin by the insulin receptor substrate-1(IRS-1)-associated 
phosphatidylinositol 3-kinase (PI3-kinase) in skeletal muscle (Hunt & Ivy 2002). Activation of PI3-kinase 
is recognized as an essential step in the activation of muscle glucose transport by insulin. However Hunt 
& Ivy (Hunt & Ivy, 2002) hypothesized that inhibition of glucose uptake by adrenaline in the presence of 
moderate physiological insulin concentration may be due to the inhibition of glucose transport rather 
than to a step distal to transport (Hunt & Ivy, 2002). The ability of adrenaline to attenuate insulin-
stimulated glucose uptake by inhibiting transport appears to be limited to insulin concentrations in the 
low to moderate physiological range, as Hunt & Ivy found in 2002.  
 
Type II diabetes can be managed or prevented by healthy diet and exercise, so obesity and physical 
inactivity in addition to genetical factors are the most important causes of this disease. Insulin resistant 
obese individuals often have abdominal obesity and high levels of LDL-cholesterol and triglycerides, and 
low level HDL-cholesterol.  This will lead to accumulation of cholesterol in the blood and results in a high 
risk of heart attack and cerebrovascular accident (CVA). It is important to mention that people with type 
II diabetes have the same risk of heart attack and CVA as the people without diabetes who have already 
had one (World Diabetes Foundation).  
In the treatment of diabetes, increasing physical activity and managing food intake toward the healthy 
sort, will give much better life with diabetes. Oral hypoglycemic medications will help to improve the 
disease and give much better control over blood glucose, but with the progression of the disease and 
after 5-10 years, many type II diabetic individuals must use insulin injection.  Depending on the 
symptoms of diabetes, medical researches continue to find new therapies for this disease. The most 
promising researches are those applied on diabetic animals. 
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1.2 Animal model (Zucker rat) 
 
Many different rodent models have been used to study the characteristics and causes of muscle insulin 
resistance, but probably the most popular model to date is the obese Zucker rat.  This rat type was 
discovered in 1961 by Lois and Theodore Zucker (Strobl et al., 1993). This model has since been well 
characterized as a model of obesity, showing commonly published metabolic symptoms including insulin 
resistance and hyperlipidemia. The obese Zucker rat is hyperphagic and demonstrates a number of 
metabolic characteristics in common with human obese subjects.  
Obese Zucker rat is the preferred rat model of insulin resistance and a combination of reduced insulin 
sensitivity and responsiveness, suggesting that its muscle insulin resistance resulted from both receptor 
and postreceptor defects. These defects included a reduced insulin receptor number and a defective 
glucose transport system. Some studies have reported that, the insulin resistance in the obese Zucker 
rats is associated with a decreased insulin binding (Crettaz et al., 1980), rate of glycogen synthesis (Ivy et 
al., 1986), and rate of glycolysis (Creattaz et al., 1983) when compared with lean littermates. Another 
study characterized the insulin receptor signaling system in skeletal muscle of the obese Zucker rat and 
found extreme insulin resistance consistent with the decrease in insulin-stimulated glucose uptake into 
skeletal muscle (Sherman et al., 1988). 
The obese Zucker rats have hyperinsulinaemia, circulating triglycerides and skeletal muscle 
triacylglycerols are higher than lean littermates (Berthiaume & Zinker, 2002). Moreover circulating non-
esterified fatty acids are increased in obese rats. This indicates that lipid utilization by muscle of obese 
rats could be increased and thereby alter glucose metabolism by the mechanism of the glucose-fatty 
acid cycle (Crettaz et al., 1980). 
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1.3 Carbohydrates  
Carbohydrates are the major source of energy for most humans and account for about 60% of the 
energy consumed (Cryer, 2002).  Most of the carbohydrates found in nature occur in the form of high 
molecular weight polymers called polysaccharides. The monomeric building blocks used to generate 
polysaccharides can be varied, however, the predominant monosaccharide found in polysaccharides is 
D-glucose. In blood, glucose is the main monosaccharide molecule. Although the utilization of energy 
varies greatly at rest and exercise, the concentration of glucose in the blood is highly regulated around 5 
mM. A reduced concentration of blood glucose will cause fatigue, and concentration below 2 mM will 
cause seizure and even death (Cryer, 2002). The high blood glucose concentration is also unhealthy 
which leads to the diabetic complications. Endocrine system is very important in the regulation of blood 
glucose concentration. Insulin and adrenaline are the most important hormones to regulate blood 
glucose concentration. 
1.4   Glycogen 
The storage form of carbohydrates in humans is glycogen, this storage is crucial to maintain blood-
glucose within narrow limits despite continuous utilization of glucose and supply of carbohydrates in 
larger meals. Despite that carbohydrates are essential, the body contains limited amount of it. Muscle 
glycogen is an important energy substrate during exercise, and the stores of glycogen limits 
performance in many types of endurance exercises (Coyle, 2000). 
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1.5  Synthesis of glycogen  
The synthesis of glycogen from glucose is carried out by the enzyme glycogen synthase, this enzyme 
utilizes UDP-glucose as substrate. Glycogen synthase exists as iso-forms, the muscle iso-form GYS1 and 
the liver iso-form GYS2.  
The activation of glucose to be used for glycogen synthesis is carried out by the enzyme UDP-glucose 
pyrophosphorylase. This enzyme exchanges the phosphate on C-1 of glucose-1-phosphate for UDP. The 
energy of the phospho-glycosyl bond of UDP-glucose is utilized by glycogen synthase to catalyze the 
incorporation of glucose into glycogen. UDP is subsequently released from the enzyme. The α-1,6 
branches in glucose are produced by amylo-(1,4–1,6)-transglycosylase, also termed the branching 
enzyme. This enzyme transfers a terminal fragment of 6-7 glucose residues (from a polymer at least 11 
glucose residues long) to an internal glucose residue at the C-6 hydroxyl position. 
 
Figure A: Glycogen synthesis. The first step in glycogen synthesis is the formation of glucose 6-phosphate mediated by 
hexokinase, then and catalysed by phosphoglucomutase, glucose 6-phosphate converts to glucose 1-phosphate which 
transformed to UDP-glucose and under the action of glycogen synthase glycogen become the end result of this 
biochemical reaction (reproduced from themedicalbiochemistrypage.org) with a special permission from Dr. Michael W. 
King). 
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1.6 Regulation of glycogen synthesis 
Regulation of glycogen synthesis occurs mainly through the regulation of glycogen synthase activity. 
Glycogen synthase activity in vivo is regulated by phosphorylation as well as the concentration of 
glucose 6-phosphate. Most likely, both mechanisms participate in regulation of glycogen synthesis, but 
their contributions in physiological conditions are still uncertain. There are large numbers of regulators 
for the glycogen synthase that reflects its crucial role in metabolic regulation. As mentioned before, the 
glycogen is the only storage form of glucose in the human body, and the tight regulation of glycogen 
synthase and phosphorylase allows blood glucose level to be maintained within narrow ranges. External 
stimuli like insulin, adrenaline and exercise regulating glycogen synthase activity via changing the state 
of phosphorylation and the concentration of allosteric activators.  
The activity of glycogen synthase is regulated by phosphorylation of serine residues. Phosphorylation of 
glycogen synthase reduces its activity towards UDP-glucose. In the non-phosphorylated state, glycogen 
synthase does not require glucose-6-phosphate as an allosteric activator; when phosphorylated it does 
(figure B).  
Furthermore, glycogen synthase activity in the absence of glucose 6-phosphate (I-form) or with low 
(physiological) concentration of glucose 6-phosphate (fractional activity) is regulated by insulin, 
adrenaline, glycogen content and muscle contraction (Jensen et al. 1999). 
Adrenaline decreases insulin-stimulated glycogen synthesis, however it does not inhibit glycogen 
synthesis after contraction (Franch et al., 1999). Glycogen synthesis needs the glucose transported 
through the cell membrane and phosphorylated to glucose 6-phosphate. During insulin stimulation and 
contraction activity, adrenaline has no effect in the transport of glucose through the cell membrane. 
(Lee et al., 1997; Aslesen & Jensen, 1998). 
 Figure B: Pathways involved in the 
 Glycogen synthase a is phosphorylated, and rendered much less active and requires glucose
activity. Phosphorylation of glycogen synthase is accomplished by several d
C (PKC), calmodulin-dependent protein kinase, glycogen synthase kinase
(CK-I and CK-II). The enzyme PKC is activated by Ca2+ ions and phospholipids, primarily diacylglycero
(reproduced from themedicalbiochemistrypage.org
 
Glycogen concentration participates in the regulation of glycogen synthase activity (Danforth, 1965)
low concentration of glycogen influences the effect of adrenaline after the contractile effect (Franch et 
al,. 1999) 
 
 
 
regulation of glycogen synthase. 
-6
ifferent enzymes such as 
-3 (GSK-3) and two forms of casein kinase 
  with a special permission from Dr. Michael W. King)
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Figure C: Pathways involved in the regulation of glycogen phosphorylase. 
PKA is cAMP-dependent protein kinase. PPI-1 is phosphoprotein phosphatase-1 inhibitor. Phosphorylase a is 
phosphorylated, and rendered highly active, by phosphorylase kinase. Phosphorylase kinase is itself 
phosphorylated, leading to increased activity, by PKA (itself activated through receptor-mediated mechanisms). 
Calcium ions can activate phosphorylase kinase even in the absence of the enzyme being phosphorylated. This is 
carried out predominately by protein phosphatase-1 (PP-1) the same phosphatase involved in dephosphorylation 
of phosphorylase (reproduced from themedicalbiochemistrypage.org with a special permission from Dr. Michael 
W. King). 
In addition to glycogen synthase, phosphorylase kinase is an important enzyme in the regulation of 
glycogen synthesis .Phosphorylase kinase activity is affected by two distinct mechanisms involving Ca2+ 
ions and PKA.  The ability of Ca2+ ions to regulate phosphorylase kinase is through the function of one of 
the subunits of this enzyme. One of the subunits of this enzyme is the ubiquitous protein, calmodulin. 
Calmodulin is a calcium binding protein. Binding induces a conformational change in calmodulin which in 
turn enhances the catalytic activity of the phosphorylase kinase towards its substrate, phosphorylase-b. 
This activity is crucial to the enhancement of glycogenolysis in muscle cells where muscle contraction is 
induced via acetylcholine stimulation at the neuromuscular junction. The effect of acetylcholine release 
from nerve terminals at a neuromuscular junction is to depolarize the muscle cell leading to increased 
release of sarcoplasmic reticulum stored Ca2+, thereby activating phosphorylase kinase. In addition to 
the increase in the intracellular calcium, the rate of muscle contraction increases glycogenolysis which 
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provides the muscle cell with the ATP it also needs for contraction. The second mechanism to control 
the activity of phosphorylase kinase is the accumulation of cAMP through the activation of β-adrenergic 
receptors by adrenaline. cAMP controls the phosphorylation of phosphorylase kinase b to 
phosphorylase kinase a (Fig. C). 
1.7 Glycogenolysis (Adrenaline effect in skeletal muscles) 
The glycogenolytic cascade begins by adrenaline stimulation to β-adrenergic receptors which stimulate 
adenylate cyclase to produce cAMP. The second step is the activation of glycogen phosphorylase and 
inactivation of glycogen synthase. The production of c-AMP by adrenaline leads the sequential 
activation of c-AMP dependent protein kinase and phosphorylase kinase. The latter kinases convert 
glycogen phosphorylase from the inactive dephosphorylated b form to the active phosphorylated a 
form, stimulating glycogenolysis in advance of an increased energy demand. It’s important to mention 
that calcium ions are important for the activity of phosphorylase kinase and the calcium channel must 
be open to sustain muscle contraction by providing energy via the breakdown of glycogen (Cohen, 
2002). 
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Figure D: cAMP mediates stimulation of glycogenolysis in muscle by β agonists (Adrenaline)  
The β-adrenergic receptor is an intrinsic component of the plasma membrane that stimulates adenylate cyclase by 
stimulatory G-protein (Gs) (Devlin, T. Textbook of Biochemistry with Clinical Correlations 6th edition). 
 
1.8  Insulin and adrenaline effects in relation to glucose kinetics 
Adrenaline normally contrasts the effect of insulin in metabolic regulation. Insulin stimulates glucose 
uptake and synthesis of glycogen and lipids leading to energy accumulation whereas adrenaline 
decreases insulin-stimulated glucose uptake, increases energy expenditure and stimulates breakdown of 
glycogen and lipids. Glucose uptake is the transport and phosphorylation of glucose by hexokinase that 
results in its clearance from the surrounding medium while glucose transport is the movement of 
glucose across the plasma membrane. 
               Insulin enhances glucose uptake through a special signaling pathway.  Insulin signaling pathway 
begins when insulin binds to its receptor (IR) on the cell surface. IR is consisting of α and β subunits, 
when insulin binds to the α-subunits of the IR, the β-subunits become phosphorylated automatically and 
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the tyrosine kinase activity stimulated. After that, insulin receptor substrate-1 phosphorylated and 
activated, IRS-1 activates phosphatidylinositol 3-kinase (PI3-kinase) and leading to the formation of 
phosphatdiylinositol (3,4,5)-triphosphate which activates phosphoinosetide-dependent protein kinase 
(PDK) and activates protein kinase-B (PKB).  PKB translocates insulin-stimulated glucose trasporter 
protein (GLUT4) which mediates glucose uptake in skeletal muscles.  Insulin also stimulates glycogen 
synthesis by activating glycogen synthase. Activation of glycogen synthase is important in the regulation 
of blood glucose, this process involves the phosphorylation of GSK-3 which is mediated by PKB. 
To clarify the mechanism by which adrenaline decreases glucose uptake, some studies have reported 
that acute exposure of isolated muscle to adrenaline or the β adrenoceptor agonist isoprenaline causes 
an activation of glycogenolysis (glycogen breakdown), and an elevation of hexose monophosphate 
concentrations and a consequent inhibition of the rate of glucose phosphorylation (Chiasson et al., 
1981; Challiss et al., 1986). Furthermore the higher plasma lactate levels, is another mechanism that 
may account for the reduction in muscle glucose uptake by adrenaline include effects on muscle glucose 
transport and/or fat metabolism (Howlett 1998). Under resting conditions adrenaline has been shown to 
decrease muscle glucose transport despite an increase in glucose transporter GLUT4 translocation to the 
plasma membrane, which suggests a reduction in GLUT4 intrinsic activity (Bonen et al. 1992).  
                  Adrenaline stimulates glycogen breakdown and causes accumulation of lactate in skeletal 
muscles (Aselen & Jensen, 1998; Jensen & Dahl, 1995; Jensen et al., 1997). This process begins with the 
activation of glycogen phosphorylase and inactivation of glycogen synthase as a result of accumulation 
of cAMP which results from β-adrenoceptor stimulation by adrenaline. Stimulated β-adrenergic 
receptors activate adenylate cyclase (AC) via stimulatory G-protein (Gαs), and activated AC will produce 
cAMP. AC activity is also regulated by inhibitory G-protein (Gαi). Jensen et al have found that β-
adrenergic stimulation by adrenaline stimulated glycogen breakdown in fast twitch muscles (type IIA 
and type IIB fibers in EDL) but not in slow twitch muscles (type I and type IIA fibers in soleus) (Jensen et 
al., 1989). In addition to the fiber type, glycogen content is of importance in the effect of adrenaline on 
glycogen breakdown in skeletal muscles. Glycogen content in type IIA fibers in EDL muscles is higher 
than glycogen content in type IIA soleus muscles and glycogen breakdown in EDL muscles stimulated by 
adrenaline infusion (Jensen et al., 1989). In 1989 Jensen et al have also reported that muscle glycogen 
content in type I soleus was higher than that in the corresponding fiber type in EDL muscles, but still 
there was no glycogen breakdown in type I soleus after adrenaline infusion (Jensen et al., 1989). In a 
later study Jensen et al. have reported a decrease in glycogen content in soleus muscles with high 
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glycogen content after 30 min incubation with adrenaline (Jensen et al., 1999). This finding indicated a 
relationship between glycogen content and adrenaline stimulated glycogen breakdown in skeletal 
muscles depending on the fiber types of these muscles. 
             It is well known that adrenaline secretion increases in response to exercise. Kjær et al (Kjær et al. 
1993) have found that adrenaline inhibits glucose clearance during exercise, they found that glucose 
clearance was higher and plasma glucose concentration decreased more rapidly during exercise when 
adrenaline secretion was inhibited by pharmacological coeliac ganglion blockade than when compared 
with exercise where adrenaline secretion was physiologically normal (Kjær et al., 1993). The mechanism 
responsible for this reduction in glucose clearance may be related to the reduced glucose utilization in 
muscle secondary to an increase in glycogenlysis, as a result of adrenergic receptor stimulation.  
 
1.9 β-adrenergic signaling and insulin resistance in skeletal muscles 
Adrenergic receptors are devided into β and α adrenergic receptors. β2 and α1 are the most expressed 
adrenergic receptors in skeletal muscles. As we mentioned before, the most important type of these 
receptors in glucose uptake and phosphorylation is β-adrenoceptors (Jensen et al., 1995). The first step 
in adrenergic signaling is the binding of adrenaline to the β-adrenergic receptors, which stimulate the 
adenylate cyclase and leads to the accumulation of cAMP and activation of PKA (Cohen, 2002). PKA is an 
enzyme consisting of two catalytic subunits and two regulatory subunits, which binds to the cAMP and 
the catalytic subunit dissociates and phosphorylates substrate proteins.  The continuous production of 
cAMP causes insulin resistance and decreases glycogen synthesis, this process is controlled by adenylate 
cyclase which balances its activity by the G-protein subunits Gαs and Gαi. 
Many previous studies have reported that adrenergic system can attenuate the effect of insulin. Katz et 
al. have found β2 agonists markedly reduced glucose tolerance and reduced the insulin response to a 
glucose challenge without altering insulin-stimulated muscle glucose uptake or transport. (Katz et al., 
1983). Another study has found that selective β2 agonist treatment also significantly reduced the fasting 
plasma insulin levels in obese zucker rats. (Torgan et al., 1993). 
1.10 β-adrenergic signaling (the role of receptor content and exercise) 
 Expression of β-adrenergic receptor is fiber type dependent, the density of β-adrenergic receptors is 
twofold higher in soleus muscles than in epitrochlearis muscles (Jensen et al., 2002).The effect of 
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adrenaline on metabolic regulation differs between muscles composed of type I and type II fibers. Slow 
twitch muscles have higher insulin-stimulated glucose uptake than fast twitch muscles, also slow twitch 
muscles have about twofold higher PKB expression and activation during insulin stimulation than in fast 
twitch muscles.  
Exercise increase β-adrenoceptor density in skeletal muscles (Williams et al., 1984). Insulin sensitivity is 
also increased after exercise, and β-adrenergic signaling is modulated in concert with insulin. In several 
physiological and pathophysiological settings, altered functional responsiveness to β-adrenergic 
receptors stimulation is associated in corresponding differences with β-adrenergic receptors density 
(Stob et al., 2007). In the sedentary compared with the exercise-trained state , Stob et al suggested that 
skeletal muscle β-adrenergic receptors density does not increase following endurance exercise training 
in healthy adult men (Stob et al., 2007).  
Skeletal muscles need energy for its mechanical action, this energy expenditure is also affected by β-
adrenergic system. The thermogenic response to the stimulation of peripheral β-adrenergic receptors is 
mediated by activation of the adenyl cyclase system, leading to increased production of cAMP 
(Nonogaki, 2000; Stob et al., 2007). Other studies have found that the β2-adrenergic receptors subtype 
has been shown to contribute significantly to β-adrenergic-mediated thermogenesis (Blaak et al., 1993, 
Stob et al. 2007). The last finding suggested that the greater thermogenic responsiveness to the β-
adrenergic receptor stimulation in trained humans is not mediated by increased expression of β-
adrenergic receptors in thermogenic tissues (Stob et al., 2007).   
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2. Aims 
 
The first aim of this study was to compare insulin-stimulated glucose uptake and glycogen content in 
soleus and EDL muscles from lean and obese Zucker rats. 
 
The second aim was to investigate the effect of adrenaline on insulin-stimulated glucose uptake and 
glycogen breakdown in normal and insulin resistant soleus and EDL muscles. 
The third aim was to compare liver glycogen content in lean and obese Zucker rats. 
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3. Materials and methods 
 
3.1  Rats and muscles 
Female lean Zucker (fa/-) and obese Zucker (fa/fa) rats (Charles River) (delivered by Folkehelsa, Oslo, 
Norway) were received at 5–6 wk of age. The animals were housed in a temperature-controlled room 
(21°C) at the Animal Facility of the National Institute of occupational health (STAMI) for 6-7 weeks. Rats 
had free access to rat chow (RM1; BK Universal, Nittedal, Norway) and water. A reversed 12:12-h light-
dark cycle was maintained (lights on 06:00 am – 0600 pm). The experiments were performed in the light 
cycle (between 10:00 am and 02:00 pm). At the day of experiments the weights of the lean rats were 
200-250g and the weights of the obese rats were 300-400g. The experiments were conducted in 
conformity with the laws and regulations controlling experiments on live animals in Norway and 
European Convention for the protection of vertebrate animals used in experimental and scientific 
purposes. 
The rats were anesthetized with an intraperitoneal injection of ~7.5 mg pentobarbital (50mg/ml) per 
100 g rat weight. Both soleus and extensor digitorium longus (EDL) muscles were surgically and carefully 
removed, soleus muscles were split by scalpel into two relatively homogenous muscles (Fig E). The 
soleus muscle was chosen for study because of our ability to section this tubular muscle longitudinally 
into  ~25-mg strips, which can be incubated with minimal limitations because of diffusion and its 
predominantly slow-twitch fiber composition: 84% type I, 16% type IIa, 0% type IIb (Ivy et al. 1996). EDL 
muscles were split by tearing along the tendons stretching to each toe resulting in deep rEDL and 
superficial wEDL (Fig F). The muscles (soleus and both EDL parts) were mounted on a contraction 
apparatus between two platinum electrodes at their resting length. The electrode was then placed in a 
test tube with 3.5 ml Krebs Henseleit buffer solution containing 5.5 mM glucose, 2 mM pyruvate, 5 mM 
HEPES and 0.1% bovine serum albumin, and gassed continuously with a gas containing 95% O2 and 5% 
CO2 through the incubation buffer for 30 min. To determine the effect of insulin concentration on 
glucose uptake and glycogen content, soleus muscles were incubated additional 30 min with insulin 0.2 
mU/ml, 10 mU/ml (Monotard, Novo Nordisk, Denmark) or kept in the buffer solution as control.  To 
determine the effect of adrenaline either on insulin-stimulated glucose uptake or glycogen content, 
soleus muscles were incubated for 30 min with insulin (10 mU/ml), adrenaline 10⁻⁶ M, epinephrine and 
insulin, or kept in the buffer solution as control (Fig E). For determination of glucose uptake and 
glycogen content in EDL muscles, after pre-incubation, wEDL muscles were then incubated with or 
without adrenaline 10⁻⁶ M {(-)-epinephrine; Sigma} for 30 min (Fig F).  
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rEDL muscles were either incubated with insulin 10 mU/ml (Monotard, Novo Nordisk, Denmark) or 
contracted electrically for 30 min with 200 ms trains (100 Hz), square wave pulses of 0.2 ms duration, 10 
V) delivered every 2 seconds. All incubations were placed in a waterbed (30° C) and gas was bubbled 
continuously through the buffer. After incubations, muscles were removed from the apparatus, blotted 
on filter paper, fixed in marked polystyrene, frozen in liquid nitrogen and stored at -70 °C until analysis 
day. 
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Fig. E. Soleus muscles incubation procedure. Muscles split into two splits, pre-incubated in the buffer solution for 
30 min and incubated in the required medium for 30 min with continues (Co2 and O2) gassing, and temperature 
adjusted on 30°C.   
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Fig. F. EDL muscles incubation procedure. The superficial part of the EDL (wEDL) were pre-incubated in the buffer 
solution for 30 min and incubated with or without adrenaline for 30 min, while the deep part of the EDL muscles 
(rEDL) were incubated in insulin or electrically stimulated for 30 min after 30 min pre-incubation in buffer solution. 
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3.2 Glucose uptake and glycogen content 
For determination of glucose uptake, 0.25 μCi/ml 2-[1,2H(N)]deoxy-D-glucose (30.6 Ci/mmol; NEN) (NET 
549 PerkinElmer) and 0.1 μCi/ml D-[1-14C]mannitol (54.5 mCi/mmol; NEN) (NEC 314 PerkinElmer) were 
added to the buffer (containing 5.5 mM glucose). Glucose uptake was calculated from the intracellular 
accumulation of 2-[³H]deoxy-D-glucose during 30 min of incubation assuming similar uptake kinetics for 
glucose and 2-deoxyglucose.  Muscles were removed from the ultra freezer (-70 °C or lower) and cut 
into two pieces at -20°C. For glucose uptake, one part  of the muscle is freeze-dried for 3 hours and 
weighed at -20°C, we used 2-3 mg of the dry weight which was enough for measurement of glucose 
uptake and glycogen content  ( concentrations between 20 and 250 mmol/kg dw) in the same sample. 
The freeze dried and weighed muscle samples are dissolved in 600 µl 1 M KOH for 20 min at 70 °C. 
After cooling down, for counting for radioactivity, 400 µl of the muscle digest were mixed well with         
3 ml of Hionic Flour scintillation cocktail (Hionic-Flour 6013319, PerkinElmer) in counting tube (Pony Vial 
6000292, PerkinElmer). After one hour, samples were counted for ³H and ¹⁴C (Tri-Carb 1900 TR, protocol 
#28, 2 cycles and 5 min counting). (Region A: 0.0-12.0 KEV for ³H, window B: 12.0-156 KEV for ¹⁴C).  
    For determination of glycogen content, glycogen in muscle samples is hydrolysed to glucose with 
amyloglucosidase (AGS) at pH 4,8, the glucose formed is specifically measured with the enzyme 
hexokinase (HK) and glucose-6-phosphate dehydrogenase (G6P-DH), (a fluorometric method published 
by Lowry and Passonneau, 1972). Amyloglucosidase hydrolyses the α-D-(1-4) and α-D-(1-6)-linkages of 
glycogen, the product is D-glucose, the glucose content after hydrolysis corresponds to the glycogen 
content of the sample. G6P-DH is specific for glucose-6-phosphate formed from glucose in the enzymatic 
reaction, the glycogen content is determined as glycosyl units.   
 
 
1)    Glycogen    amyloglucosidase >  glucose 
2)    Glucose + ATP   hexokinase >  glucose-6-phosphate + ADP 
(3)  Glucose-6-P + NADP+  G6P-DH > 6-P-gluconolactone + NADPH + H+ 
Glucose is phosphorylated in reaction 2 to glucose-6-phosphate and G-6-P oxidises with NADP+ in 
reaction 3. The equilibrium in reaction 3 lies on the side of G-6-P reduction and the glucose liberated 
after hydrolysis of glycogen is proportional to the increase of NADPH measured as change in 
fluorescence at wavelength 340 nm (excitation) and 460 nm (emission). The muscles sample is dissolved 
in 600 µl 1 M KOH and analysed together with controls (10 µl glycogen control solution {glycogen Sigma 
26 
 
G-8876 rabbit liver} ~50 mM into 600 µl 1 M KOH{Merck 5021, MW 56,11, min 85%}), for hydrolysis of 
muscles, 100 µl of muscle digest samples and 25 µl 7 M acetic acid were mixed with 500 µl 0.3 M 
acetate buffer  (35,4 ml 0.3 M Na-Acetate {Merck 6268, MW 82.03, 99%} + 24,6 ml 0.3 M acetic acid 
{Merck, MW 60.05, 100%, d=1,05}), incubated for 3 hrs at 37 °C and the hydrolysates stored at -20 °C or 
analysed directly for glucose. In glucose analysis we used fluorescence range 0.5-10 µM in the cuvette 
and the wavelength was 340 and 460 nm. For calculation of glycogen concentration in muscles samples, 
we made a standard curve from 4-6 concentrations which depends on the glycogen content in the 
muscle samples, we calculated the regression line from the standard curve y= Ax + B, where A is the 
slope of regression line, x=µM in the cuvette and B is the intercept with the y axis, the rest of the 
calculations were done upon the dilutions used in this protocol. 
3.3 Liver glycogen  
The liver tissue samples weighed ~ 5-10 mg at -20°C and freeze dried up to  ~ 3 hrs, the relation 
between the dry weight and the wet weight for liver is 0.3. 1-3 mg dry weight was enough for 
calculation of the glycogen concentration between 500 and 1500 mmol/kg dw. Each liver sample of the 
two freeze dried and weighed muscle samples added to 3000 µl 1 M HCl (Merck p.a. 317 (~37 %)), 
samples were incubated 2.5 hrs in 100 °C heating block, mixed gently and cooled down, the evaporated 
water compensated. HCL broke glycogen down to glucose. The glucose analysis is done just as 
mentioned in the determination of glycogen content in muscles except that the hydrolysates were 
centrifuged at +4 °C, 3000 g for 5-10 min and diluted (100 µl hydrolysate + 300 µl 1 M HCl) as we 
expected high levels of glycogen. 
3.4 Statistics 
Data are presented as means ±SEM. One way ANOVA was performed to determine the P-value, the level 
of significance been chosen is 0.05, when ANOVA revealed significant differences, Least Significant 
Differences were performed to compare groups. All tests have been performed using SPSS, p<0.05 
considered statistically significant.  
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4 Results 
 
 4.1 Glucose uptake and glycogen breakdown 
Glucose uptake in control soleus muscles from lean Zucker rats was 3.48 ± 0.39, and 2.00 ± 0.11 
mmol/kg dw/30 min for obese rats. Glucose uptake in the presence of 0.2 mU/ml insulin was more than 
twice as high in muscles from lean rats compared to muscles from obese rats (p<0.01 Fig. 1A). In 
muscles treated with 10 mU/ml insulin, glucose uptake was ~ 5 times as high as basal glucose uptake in 
lean rats and was twice as high as in muscles from obese Zucker rats, (p<0.01 Fig. 1A). 
 
             
Fig. 1A Glucose uptake in soleus muscles from lean and obese Zucker rats incubated with different insulin 
concentrations.  
Data presented are means ± SEM, n=12. 
(a) Significantly different from muscles taken from lean rats treated similarly. 
(b) Significantly different from control muscles. 
 
Glycogen content in control soleus muscles from lean Zucker rats was 126.1 ±6.7 mmol/kg dw, in obese 
rats, glycogen content was ~15% higher than that in muscles from lean Zucker rats (p<0.05). With 
physiological insulin concentration, glycogen content was 121.3 ± 7.5 mmol/kg dw in muscles taken 
from lean rats, in muscles from obese Zucker rats, glycogen content was ~24% higher than that in lean 
Zucker rats (p<0.05 Fig. 1B). High insulin concentration showed no significant effect on glycogen content 
in both lean and obese rat muscles (p>0.05).   
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Fig. 1B Glycogen content in soleus muscles from lean and obese Zucker rats. Muscles were treated with 
physiological insulin concentration 0.2mU/ml, with maximal insulin concentration 10mU/ml or kept rested. All 
muscles were incubated for 30 min. at 30° C with continues CO2 and O2 gassing.  
 Data presented are means ± SEM, n=12. 
(a) Is significantly different from lean rat muscles treated similarly. 
 
 Table 1  
The effect of electrical stimulation on glycogen content in soleus muscles from lean and obese Zucker rats.  
                                                                   Glycogen content (mmol/kg dw) 
                                                       Basal                                                               Electrical stimulation  
Lean                                            126.1 ± 6.72                                                            75.2 ± 4.57* 
Obese                                          144.2 ± 5.09†                                                         97.6 ± 4.58*† 
Muscles from lean and obese rats were electrically stimulated for 30 min or kept rested.  
Data presented are means ± SEM, n=12. 
*significantly different from control 
†significantly different from lean rat muscles treated similarly. 
In another set of experiments glucose uptake in control soleus muscles from lean Zucker rats was      
3.19 ± 0.41 and 1.71 ± 0.27mmol/kg dw/30 min in soleus muscles from obese Zucker rats. Insulin 
increased glucose uptake in lean rat soleus muscles ~ 5 times, and glucose uptake was more than twice 
as high in solues muscles from obese rats than in control muscles (p< 0.01 Fig. 2A). Muscles incubated 
with adrenaline alone showed no difference in glucose uptake from control muscles. Adrenaline 
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decreased insulin-stimulated glucose uptake in lean rat muscles by ~35%, and by ~15% in obese rats 
muscles (p<0.01). However the glucose uptake doubled by the combination action of insulin and 
adrenaline in both lean and obese rats compared to control.   
 
              
Fig.  2A Effect of adrenaline on Insulin-stimulated glucose uptake in soleus muscles from lean and obese 
Zucker rats. The same insulin concentration used 10 mU/ml, muscles were incubated for 30 min at the 
same temperature 30°C. 
Data presented are means ± SEM n=6-7. 
(a) Significantly different from control muscles. 
(b) Significantly different from lean rat muscles. 
In control rested soleus muscles glycogen content was 117.6 ± 10.1 mmol/kg dw/30 min for muscles 
taken from lean Zucker rats (Fig. 2B). In muscles taken from obese Zucker rats glycogen content was 
~30% higher than that in control muscles from lean rats, (p<0.05 Fig. 2B). In insulin incubated muscles, 
glycogen content was not significantly different from control in both muscles from lean and obese rats, 
(p = 0.085). Glycogen content in adrenaline incubated muscles from lean rats was 112.5 ± 9.6 mmol/kg 
dw. In muscles taken from obese Zucker rats, glycogen content was ~25% higher than that inmuscles 
from lean rats, (p< 0.05 Fig 2B). Adrenaline and insulin showed no significant effect on glycogen content 
in both lean and obese Zucker rats, (p>0.05; Fig 2B). 
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Fig. 2B Effect of adrenaline on glycogen content in soleus muscles from lean and obese Zucker rats. 
Muscles were incubated for 30 min. Maximum insulin concentration 10mU/ml and 10⁻⁶ M adrenaline were used. 
Data presented are means ± SEM n=6-7. 
(a) Significantly different from lean muscles treated similarly. 
 
 
Table 2  
 The effect of electrical stimulation on glucose uptake in soleus muscles from lean and obese Zucker rats.  
Glucose uptake (mmol/kg dw/30min) 
                                                       Basal                                                            Electrical stimulation 
Lean                                            3.48 ± 0.39                                                         8.34 ± 0.49 * 
Obese                                         2.00 ± 0.11 †                                                      5.18 ± 0.39 *† 
Muscles contracted isometrically for 30 min or kept rested in the continuous gassed buffer solution. The 
temperature were kept on 30°C. 
Data presented are means ± SEM where n=12. 
*Significantly different from control muscles. 
† Significantly different from lean rat muscles treated similarly. 
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In white EDL muscles from lean Zucker rats, basal glucose uptake was 4.12 ± 0.43 mmol/kg dw/30 min. 
Basal glucose uptake in muscles from obese Zucker rats was ~30% lower than that in lean rat muscles 
(p>0.05 Fig. 3A). Compared to control muscles, adrenalin decreased glucose uptake by ~40% in muscles 
from lean Zucker rat (p<0.05) while the effect of adrenaline showed no significant decrease in glucose 
uptake in white muscles from obese Zucker rat compared to control muscles (Fig. 3A).  Insulin-
stimulated glucose uptake in lean rat muscles was 12.27 mmol/kg dw/30min.Glucose uptake in obese 
rat muscles was  ~50% lower than that in lean rat muscles (Fig. 3B). Contraction-stimulated glucose 
uptake in lean rat muscles was rather similar to insulin-stimulated glucose uptake. In obese Zucker rat 
muscles, contraction-stimulated glucose uptake was 35% lower than in muscles from lean Zucker rats 
(p<0.01; Fig 3B).  
              
Fig. 3A The effect of adrenaline on glucose uptake in white EDL muscles from lean and obese Zucker rats. 
Muscles were incubated for 30 min with or without 10⁻⁶ M adrenaline. 
(a) Significantly different from control muscles. 
Data used are means ± SEM n=7-8. 
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Fig. 3B The effect of insulin and electrical stimulation on glucose uptake in red EDL muscles from lean and obese 
Zucker rats. Muscles were incubated in 10 mU/ml insulin solution or electrically stimulated, all muscles were 
incubated for 30 min. 
(a) Significantly different from lean rat muscles treated similarly. 
         Data presented are means ± SEM n=7-8. 
        
                        
       
     Glycogen content in control white EDL muscles from lean Zucker rats was 154.0 ± 7.6 mmol/kg dw. In 
obese Zucker rats glycogen content was ~20% higher (p<0.05 Fig. 4A). Adrenaline slightly decreased 
glycogen content in muscles from lean rats (~ 13%; p=0.078), while in obese rats, glycogen content 
decreased by ~15% (p<0.05; Fig 4A). In red EDL muscles from lean rats incubated for 30 min with 
insulin, glycogen content was 134.1±11.7 mmol/kg dw, while in red EDL muscles from obese Zucker rats 
treated similarly, glycogen Content was ~10% higher than in muscles from lean rats (Fig. 4B). Electrical 
stimulation decreased glycogen content by ~40% in lean rat red EDL muscles and ~45% in obese rats 
(p<0.05; Fig 4B).  
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Fig. 4A The effect of adrenaline on glycogen content in white EDL muscles from lean and obese Zucker rats. 
Muscles were incubated with or without 10⁻⁶M adrenaline for 30 min at 30° C. 
(a) Significantly different from lean rat muscles treated similarly. 
(b) Significantly different from control muscles. 
Data presented are means ± SEM n=7-8. 
 
 
              
Fig. 4B The effect of insulin and contraction on glycogen content in red EDL muscles from lean and obese Zucker 
rats. Muscles were incubated in 10mU/ml insulin or contracted for 30 min. 
Data presented are means ± SEM n=7-8. 
(a) Significantly different from electrically stimulated muscles. 
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4.2 Liver glycogen and muscle weight 
In lean rats, liver weight was 9.17 ± 0.32 g but the liver weight in obese Zucker rats was ~ 60% higher. 
Liver glycogen contents were not significantly different between genotypes, although they tended to be 
lower in lean Zucker rats (Table 3). Lean rats body weight was 226.1 ± 4.0 g while obese Zucker rat 
weight was ~60% higher, despite this result the EDL muscle weight in lean Zucker rat was 116.4 ± 2.9 mg 
which is ~20% higher than EDL muscle weight in obese Zucker rats (Table 3). 
Table 3  
Lean and obese rats liver weight, glycogen content and EDL muscles weights.    
                  Body wt.     Liver wt.            Liver glycogen          Body wt.               Liver/BW               EDL wt.  
                      (g)                 (g)                   (mmol/kg dw)               (g)                                                       (mg) 
Lean         226.1±4.0    9.17±0.32          1212.0±53.0             226.1±4.0          0.041±0.001          116.4±2.9 
Obese      359±4.8        14.91±0.63*      1335.8±55.6             359±4.8†           0.042±0.001          97.5±2.1‡ 
*Significantly different from lean rat liver weight. 
†Significantly different from lean rat weight. 
‡Significantly different from lean rat EDL weight. 
Data presented are means ± SEM, EDL weights are means of EDL left and EDL right. n=12. 
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5 Discussion 
 
             Insulin resistance is the most common feature in most types of human and animal obesities. we 
have investigated insulin resistance in skeletal muscles because skeletal muscles make up about 40% of 
the body weight and nearly 70-90% of insulin stimulated glucose disposal is incorporated into muscles 
glycogen (Shulman et al., 1990). Skeletal muscles are also responsible for at least 80% of glucose uptake 
in humans during insulin stimulation (DeFronzo et al., 1981). Skeletal muscle is a specialized tissue for 
movement where chemical energy is transformed into mechanical work. Skeletal muscles have also an 
important role for regulation of blood glucose. Skeletal muscle insulin resistance is of special interest as 
far as the chronic insulin resistance is believed to be in large part, due to insulin resistant muscle tissue 
(Ivy et al., 1986). Skeletal muscles insulin resistance can be described as predisposing force and an 
underlying feature of type-2 diabetes. This fact has led to many researches on the insulin resistance of 
the skeletal muscles of the genetically obese Zucker rats (Ivy et al., 1986). 
 
              The obese Zucker rat is a preferred rat model for insulin resistance due to a combination of 
reduced insulin sensitivity and responsiveness. Obese Zucker rats have a reduced number of insulin 
receptors at the plasma membrane and a defect in the insulin-stimulated glucose transporter 4 (GLUT4) 
translocation process (Sherman et al., 1988; Etgen et al., 1996). Some studies have reported that, the 
insulin resistance in the obese Zucker rats is associated with a decreased insulin binding (Crettaz et al., 
1980), rate of glycogen synthesis (Ivy et al., 1986), and rate of glycolysis (Creattaz et al., 1983) when 
compared with lean littermates. Other factors may play a major role in bringing about insulin resistance 
in the obese Zucker rats, such as the decreased ability of liver, adipose tissue, and muscle to bind insulin 
(Crettaz, et al., 1980).  Previous studies have characterized the insulin receptor signaling system in 
skeletal muscle of the obese Zucker rat and found extreme insulin resistance consistent with the 
decrease in insulin-stimulated glucose uptake into skeletal muscle (Ivy, J. 2001; Sherman et al., 1988). 
Furthermore, Sherman et al (Sherman et al., 1988) have demonstrated that the glucose transport 
process is the major site of skeletal muscle insulin resistance in the obese Zucker rats. 
              Skeletal muscles of the obese Zucker rats differs from those of lean animals in two respects; 1) 
lower insulin sensitivity associated with reduced insulin binding, and 2) lower response to insulin which 
may also decreased upon the additional changes in the utilization of glucose beyond the interaction of 
insulin with its receptor (Crettaz et al 1980; Smith & Czech, 1983). Insensitivity to insulin in large portion 
of the peripheral tissues could contribute to insulin resistance in Zucker fatty rat in vivo (Smith & Czech, 
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1983). Because insulin controls its own receptors, hyperinsulinemia has been blamed for the reductions 
in binding and sensitivity in adipocytes as well as for the overeating and excess fat storage that cause 
obesity itself. Previous studies have reported that the response of the peripheral tissues to the maximal 
insulin concentration, which tests glucose disposal beyond the insulin-receptor interaction, was also 
impeded. Therefore, defective transport or metabolism of glucose in skeletal muscles throughout the 
body can play a major role in the production of whole body resistance to insulin (Crettaz et al., 1980; Ivy 
et al., 1989).   
             Other studies have characterized the insulin receptor signaling system in skeletal muscles of the 
obese Zucker rat and found extreme insulin resistance consistent with the decrease in insulin-stimulated 
glucose uptake into skeletal muscles (Sherman et al., 1988). In skeletal muscles, insulin stimulates 
glucose uptake via translocation of GLUT4 from intracellular vesicles to the cell membrane. Upon insulin 
binding, the insulin receptor becomes tyrosine phosphorylated, and recruits IRS for tyrosine 
phosphorylation. After tyrosine phosphorylation, IRS-1 binds and activates the enzyme 
phosphatidylinositol 3-kinase (PI3K). PI3K activation results in serine phosphorylation of protein kinase B 
(PKB), and ultimately, stimulation of glucose transport in skeletal muscles. IRS-1 acts as metabolic switch 
for the insulin signaling pathway. In insulin resistant muscles a Serine/threonine phosphorylation of IRS-
1 can result in suppression of the insulin signaling pathway (Gupte et al., 2008). This pathway 
suppression results in insulin inability to translocate GLUT4 to the cell membrane and to activate 
glycogen synthase (Etgen et al., 1996; Etgen et al., 1997). In addition, activation of key proteins in the 
insulin signaling pathway is reduced, as well as a reduction in PI 3-kinase and PKB activation have been 
associated with insulin resistance (Widegren et al., 1998; Christ et al., 2001).   
          In the present study, glucose uptake in the obese Zucker rat muscles was lower than that in lean 
littermates. Our data showed very low glucose uptake in soleus muscles from obese Zucker rats 
incubated with physiological insulin concentration, and the physiological insulin concentration did not 
significantly increase glucose uptake. In contrast, glucose uptake was doubled at physiological insulin 
concentration in muscles from lean Zucker rats. These results are comparable with other previously 
reported results such as Crettaz et al. (Crettaz et al., 1980) who studied insulin sensitivity in vitro and 
found that muscles from obese Zucker rats were less insulin-sensitive than muscles from lean rats. They 
also suggested that glucose uptake in muscles of obese Zucker rats was characterized by a decrease in 
both insulin-sensitivity and insulin-responsiveness (Crettaz et al., 1980). Agreeing with this suggestion, 
my results showed that glucose uptake in lean rat muscles incubated with maximal insulin concentration 
was much higher than glucose uptake in obese Zucker rat muscles (fig 1A & 1B).  
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         Other agreeing In vivo studies have shown that, insulin-stimulated hind-limb glucose uptake was 
significantly reduced in the obese Zucker rats compared with lean Zucker rats in the absence of insulin 
and at physiological, sub-maximal and maximal insulin concentrations (Ivy et al., 1988; Ivy, J. 2001). Ivy 
et al. (Ivy et al., 1988) have suggested that the muscles insulin resistance of the obese rat is due to 
reduced insulin responsiveness and not sensitivity. Leonard et al. have used Zucker diabetic fatty (ZDF) 
rats and found that the decrease in glucose uptake in skeletal muscle of obese animals is paralleled by a 
decrease in glycogen synthesis and storage in these tissues (Leonard et al., 2005). I suggest that 
impaired glucose uptake in the obese rat muscles is due to a defect in insulin sensitivity and 
responsiveness as glucose uptake was lower in physiological and high insulin concentrations.  
             I have demonstrated that adrenaline decreased insulin-stimulated glucose uptake in soleus 
muscles from lean and obese Zucker rats and wEDL muscles from lean Zucker rats. Aslesen and Jensen 
(Aslesen & Jensen, 1998) agreed with these results as they found that adrenaline decreased insulin-
stimulated glucose uptake, but adrenaline did not influence glucose uptake in the absence of insulin. 
This result is consistent with an in vivo study done by Chiasson et al. (Chiasson et al. 1981) where insulin-
stimulated glucose uptake in hind-limb of fed rats decreased by adrenaline. Another study supporting 
my findings is Rattigan et al. (Rattigan et al., 2001) who have shown that nor-adrenaline reduces glucose 
uptake via α-adrenergic regulation of blood flow. But blood flow is without effect in the present study 
since muscles were incubated in vitro. Furthermore, I did not investigate which subtype of adrenergic 
receptors that mediated the effect. It`s most likely via β-adrenergic effect on the muscle fibers. I suggest 
that β-adrenergic signaling is not impaired in insulin-resistant muscles. Stimulation of β-adrenergic 
receptors by adrenaline increases the concentration of glucose 6-phosphate which inhibits hexokinase 
activity. Inhibition of hexokinase activity decreases glucose phosphorylation which results in the 
reduction of glucose uptake (Aslesen & Jensen 1998). Some studies have also found that adrenaline has 
an indirect effect on glucose level through stimulation to hepatic glucose production by increased 
gluconeogenesis as a result of accelerated muscle glycogenolysis and lactate release (Sonne et al., 1987; 
Wasserman et al., 1987; Howlett et al., 1999).  
                In this study I investigated the effect of in-vitro electrical stimulation on glucose uptake in 
soleus and EDL muscles from lean and obese Zucker rats. Contraction-stimulated glucose uptake in 
obese Zucker rat EDL muscles was lower than that in lean rat muscles. While contraction-stimulated and 
insulin-stimulated glucose uptakes were the same in soleus muscles from lean Zucker rats, contraction-
stimulated glucose uptake was higher than insulin-stimulated glucose uptake in muscles from obese 
Zucker rats. The well known treatment to enhance skeletal muscles insulin action is exercise          
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training (Ivy et al., 1986). This study suggested that the exercise training in combination with the high-
carbohydrate diet functioned synergistically to improve the insulin-stimulated glucose uptake in the 
muscle of the obese Zucker rat (Ivy et al., 1986). Our results agree with many previous studies who have 
documented that exercise training enhances insulin stimulation of skeletal muscle glucose uptake in 
both normal and obese rats (Mondon et al., 1980; Ivy et al., 1983). Also, some studies have reported a 
slight reduction in contraction-stimulated glucose transport in muscles from obese Zucker rat compared 
to lean phenotypes (Henriksen & Jacob, 1995; Dolan et al., 1993). Others have reported that contraction 
normally stimulates glucose uptake in muscles from obese Zucker rats (Brozinick et al., 1992; Etgen et 
al., 1996). In a submitted study from the laboratory where I did my experiments, Lin et al (Lin et al., 
submitted) have reported that contraction stimulated glucose uptake and GLUT4 expression in the 
obese Zucker rat skeletal muscles was lower than that in the lean phenotypes. Ivy et al (Ivy et al., 1983) 
concluded that in vivo aerobic exercise training improved glucose tolerance and insulin sensitivity in the 
obese Zucker rat. This improvement is propably due to the reduction in the size of the adipocytes, this 
improvement did not persisted for a long time and the adipocytes regain their large size after cessation 
of the exercise (Ivy et al., 1983).  
                   In order to further investigate the effect of the muscle type in the glucose uptake and 
glycogen content I used slow twitch (Soleus) and fast twitch muscles (EDL). Rodent’s fast-twitch white 
fibers (type IIb) are considered to be glycolytic, metabolizing glycogen to lactate as the primary fuel for 
contraction and showing signs of fatigue when glycogen stores are depleted. Fast-twitch red fibers (type 
IIa) are both glycolytic and oxidative in that glucose is metabolized both aerobically and anaerobically. 
Jensen and Dahl (Jensen & Dahl, 1995) have indicated that the ability of adrenaline to stimulate 
glycogen breakdown in resting muscles in vivo seems to depend on the muscle fiber type composition of 
the intended muscle. They found that glycogen breakdown was more pronounced in type IIB fibers than 
in type I and type IIA (Jensen & Dahl, 1995).   
                In this study, glycogen content was higher in soleus muscles from obese Zucker rats than that in 
lean littermates. This finding agrees with Ruzzin & Jensen (Ruzzin & Jensen 2005) who used 
dexamethasone-treated rat muscles as insulin resistant muscles and found glycogen content in insulin 
resistant muscles was higher than that in normal muscles. This study showed no effect of adrenaline on 
glycogen content in soleus muscles from lean and obese Zucker rats which agree with Jensen et al 
(Jensen et al., 1989; Jensen et al., 1999). In consistent results, my study showed no effect of adrenaline 
on glycogen content in soleus muscles from lean and obese Zucker rats. Some previous studies have 
reported that, slow twitch (soleus) muscles exhibit little glycogen phosphorylase activation in response 
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to adrenergic stimulation and no glycogen breakdown is seen (Rennie et al., 1982; Richter, EA. 1984; 
Peters et al., 1998). Several studies have found that adrenaline stimulated glycogen breakdown in fast 
twitch rat skeletal muscles (Chasiotis, 1985; Jensen et al., 1989; Jensen & Dahl, 1995). The present study 
is the first to report that adrenaline stimulated glycogen breakdown in EDL muscles from obese Zucker 
rats.  Adrenaline slightly stimulated glycogen breakdown in the correspondent muscles from lean 
littermates, but during adrenaline stimulation, the major part of glycogen phosphorylase is 
phosphorylated and transformed from the b (inactive) form to the a (active) form in fast-twitch (EDL) 
muscles. Adrenaline is also a strong inhibitor of glycogen synthase and decreases its activity to low level, 
adrenaline also blocks insulin-mediated activation of glycogen synthase. This notion been proved by 
Jensen et al (Jensen et al. 1999) who found that adrenaline  decreased the fractional activity of glycogen 
synthase to low levels in insulin-stimulated non-contracted muscles. It is important to remember that 
glycogen synthase activity in vivo is regulated by phosphorylation as well as the concentration of glucose 
6-phosphate, but in the absence or low concentrations of glucose 6-phosphate, glycogen synthase 
activity is regulated by insulin, adrenaline, glycogen content and muscle contraction.  
                  My data showed that electrical stimulation decreased glycogen content in rEDL muscles in 
lean and obese Zucker rats. Previous studies supported this finding either directly by measuring 
glycogen content (Chesley et al., 1995) or indirectly by measuring glycogen synthase fractional activity 
(Nielsen et al., 2001). Chesley et al. have found that intense aerobic exercise is likely to fully activate 
glycogenolysis via increased calcium release (Chesley et al., 1995). But glycogen synthase fractional 
activity increased after contraction and Nielsen et al., suggested that this result is a feed-back 
mechanism to the glycogen breakdown resulted from contraction and furthermore they suggested that 
this mechanism is the only mechanism which control glycogen synthase fractional activity (Nielsen et al., 
2001). But another study indicates that contraction increased glycogen synthase fractional activity more 
than expected from the decrease in glycogen content (Jensen & Lai, 2009).  Lin et al (Lin etal., 
submitted) have found that glycogen synthase total activity was slightly reduced by muscle contraction 
and glycogen content was reduced to similar level in muscles from lean and obese Zucker rats.  
                 Although the body and liver weights of the obese Zucker rats were significantly higher than in 
lean littermates, liver glycogen content in obese Zucker rats was not significantly different from that in 
lean phenotypes. This result is comparable with Bruce et al (Bruce et al., 2001) who found that liver 
glycogen content at rest in obese Zucker rats was not significantly higher than that in lean phenotypes. 
In the same study, carbohydrates refeeding did not restore the depleting liver glycogen in obese Zucker 
rat after exercise (Bruce et al., 2001). These results lead us to conclude that, the obese Zucker rat is 
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hyperphagic and usually converts carbohydrates to fat not glycogen or protein. As far as the fat 
production occurs only in the liver, this mission needs a larger liver size in obese Zucker rats than lean 
phenotypes. Also the obese Zucker rat liver colour was pale which indicates more fat content.  These 
results can clarify that the obesity is a result of failure in the process of the gluconeogenesis in the liver 
as well as a decreased glucose uptake and decrease muscle gluconeogenesis. In conclusion, adrenaline 
decreased insulin-stimulated glucose uptake in normal and insulin resistant rat skeletal muscles, also 
adrenaline found to enhance glycogen breakdown in the insulin resistant EDL muscles while slightly 
enhanced glycogen breakdown in the correspondent muscles of the lean rat. I suggest that β-adrenergic 
signaling is not impaired in insulin resistant rat muscles. 
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6 Conclusions 
 
 
1- Insulin-stimulated glucose uptake was lower in soleus muscles from obese than in muscles from 
lean Zucker rats at physiological and supra physiological insulin concentrations.  
 
2- Glycogen content was slightly higher in soleus and EDL muscles from obese rats compared to 
muscles from lean rats. 
 
3- Adrenaline decreased insulin-stimulated glucose uptake in both normal and insulin resistant 
muscles. However, the reduction was higher in muscles from lean rats than in muscles from 
obese rats. 
 
4- Adrenaline decreased glycogen content in insulin resistant muscles but did not significantly 
decrease glycogen content in normal muscles. 
 
5- Despite the higher weight of obese rats than lean rats, the weight of the EDL muscles from 
obese rats were lower than weight of EDL muscles from lean Zucker rats. 
 
6- The liver weight was higher in obese Zucker rats than liver weight in lean Zucker rats but the 
glycogen content was similar. 
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Appendices 
Appendix 1:  Glycogen content 
REAGENTS AND SOLUTIONS 
1 M potassium hydroxide,KOH: 
16,5g KOH Merck 5021 (MW 56,11 ,  min 85%) + H2Omillipore up to 250 ml. 
Store at + 4°C. 
50 mM glycogen: 
40,5 mg glycogen Sigma G-8876 (rabbit liver) + 5 ml H2O millipore. 
Mix well, make up portions and store at -20°C. 
0,3 M sodium acetate, CH3COONa:  
12,43 g Na-Ac Merck 6268 (MW 82,03 , 99%) + H2O millipore up to 500 ml. 
Store at + 4°C.  
0,3 M acetic acid, CH3COOH: 
8,58 ml concentrated acetic acid Merck ( MW 60,05 , 100% , d=1,05) +  H2O millipore up to 500 ml. Store at 
+ 4°C.  
Amyloglucosidase: 
Boehringer 208 469 (EC 3.2.1.3) from Aspergillus niger - about 6 U/mg solid (25°C - glycogen as a 
substrate). Store dry at + 4 °C and take out the right amount when preparing the AGS mixture. Not 
produced anymore. We recommend to try Roche  cat.No.1 202 332. 
7 M acetic acid, CH3COOH: 
2 ml concentrated acetic acid Merck  ( MW 60,05 , 100% , d=1,05) + 3 ml H2O millipore.  
Standard solution, D-glukose, 10 mM: 
495,42 mg D(+)glucose Merck 8342 (monohydrate MW 198,17) + H2O millipore up to 250 ml. Make up 
portions and store at -20°C. 
1 M Tris/HCl-buffer pH 8,1: 
12,1 g Trizma Base Sigma T-1503 (MW 121,1) +  4 ml concentrated  hydrochloride (HCl, Merck p.a. 317, 
min. 37%). Add H2O millipore up to 75 ml. 
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Mix well and adjust to pH  8,1. 
Add H2O millipore up to 100 ml. Store at - 20°C. 
1 M magnesium chloride, MgCl2: 
2,03 g MgCl2·6H2O Merck 5833 (MW 203,3) + H2O millipore up to 10 ml. 
Store at - 20°C. 
0,5 M dithiothreitole, DTT: 
77,2 mg DTT (Cleland reagens) Sigma D-0632 (MW 154,3 ca.99%) + 1 ml H2Omillipore. Store at -20°C. 
100 mM adenosine-5-triphosphate, ATP: 
123 mg ATP Sigma A-2383 ( with teoretical MW 614,2 , 99% pure - 3,5 H2O and 2 Na/mol) + 2ml H2O 
millipore. Mix and add  6 N NaOH (50 - 60 µl) to pH 7 - 7,5. See datasheet for information. 
Store at - 20°C. 
50 mM nicotinamide-adenine dinucleotide phosphate, NADP+: 
21 mg NADP+ Sigma N-0505 (MW for free acid 743,4 - see datasheet and label for exact information on 
each batch). Add 500 µl H2Omillipore. Mix and store at - 20°C, 100 µl in each tube. 
1% Bovine Serum Albumin: 
100 mg albumin Sigma A-4503 + H2Omillipore up to 10 ml. 
Mix gently, to avoid foam. Dissolve slowly. Store at - 20°C. 
1 mg/ml glucose-6-phosphat dehydrogenase, G6P-DH: 
Boehringer 127 035,type I  (EC 1.1.1.49) from yeast - about. 350 U/mg. 
10 mg/ml hexokinase, HK: 
Boeringer 127 809  (EC 2.7.1.1) from yeast - about 140 U/mg. 
Mix well before use. 
Enzyme dilution buffer (20 mM Tris/HCl w/0,02% BSA pH 8,1): 
1 M Tris/HCl pH 8,1   100 µl 
1% Bovine Serum Albumin   100 µl 
H2Omillipore  up to        5 ml                                           Store at -20°C. 
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Appendix2: E-mail from Dr. Michael W. King 
Nader Alhaj <nader.alhaj@gmail.com> Wed, Dec 16, 2009 at 8:13 PM 
To: "King, Michael W" <miking@iupui.edu> 
Dear Mr. King, 
I've talked to you about glycogen synthase and the information from your web page 
medicalbiochemistrypage, 
I've got the text book you recommended to me, it was very helpfull and I really thank you for this great 
recommendation, I am sending this mail to kindly ask you for a permission to use some figures from 
your 
page in my thesis. 
Kindest regards. 
Nader Alhaj 
Master student 
School of pharmacy 
University of Oslo 
Norway 
+47 97970747 
[Quoted text hidden] 
King, Michael W <miking@iupui.edu> Mon, Dec 21, 2009 at 8:59 PM 
To: Nader Alhaj <nader.alhaj@gmail.com> 
Dear Nader: 
If you ensure that you include the proper citation as to the source of the images from my web site then 
you may reproduce them in your thesis. Please indicate that the images are reproduced from http:// 
themedicalbiochemistrypage.org with permission from Dr. Michael W. King 
Sincerely, 
Dr. King 
___________________________________ 
Michael W King, PhD 
Professor 
IU School of Medicine and 
Center for Regenerative Biology and Medicine 
620 Chestnut St, Room 135HH 
Terre Haute, IN 47809 
812-237-3417 
miking@iupui.edu 
From: Nader Alhaj [nader.alhaj@gmail.com] 
Sent: Wednesday, December 16, 2009 1:13 PM 
To: King, Michael W 
Subject: Re: Glycogen synthase 
[Quoted text hidden] 
Nader Alhaj <nader.alhaj@gmail.com> Mon, Dec 21, 2009 at 10:53 PM 
To: "King, Michael W" <miking@iupui.edu> 
Dear Dr. King, 
thank you too much, I will do it properly. 
Kindest regards. 
Nader Alhaj. 
[Quoted text hidden] 
 
